ClinicalTrials.gg
RecruitingNCT05315752Updated Feb 13, 2024

Changes in Body Fat and Morphologic Characteristics Associated With OSA Resolution After Bariatric Surgery

An observational study in Obesity and Obstructive Sleep Apnea, sponsored by Centre Hospitalier Universitaire Saint Pierre. Recruiting at 2 sites in Belgium. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2024-02-13.

Sponsored by Centre Hospitalier Universitaire Saint Pierre · Observational

How we know

From the registry’s dates

  • Started Apr 2022; still recruiting 4 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 133 studies in Obesity with a site in Belgium — 40 open to participants now, 56 under way, 22 of them phase 3. Obesity · Belgium.

Planned enrollment
29th of 35
60 · median 150
Started
2022
with 6 others
Observational
35 of 133
16 open now
Primary completion
2026-12
later than 18 of 55 live
Registered
82nd of 133
by date

Among the 133 studies in Obesity with a site in Belgium, this one is the 29th largest by planned enrollment of the 35 observational ones that give a count, is one of 7 that started in 2022, is one of 35 observational ones, reaches primary completion later than 18 of the 55 other live ones, and was the 82nd registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

40 of the 133 studies in Obesity with a site in Belgium are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 133 studies in Obesity with a site in Belgium, or all of them as a file.
02

Study summary

Prospective study with inclusion of bariatric surgery candidates with diagnosed Obstructive Sleep Apnea and requiring treatment with Continuous Positive Air Pressure, aiming to evaluate at 2-6-12 months after bariatric surgery whether the relationship between biometric changes (reduction in neck circumference, height, waist/hip ratio, and fat and lean mass) and the resolution of OSA is better than the relationship between these biometric changes and BMI reduction.

Read the detailed description

Investigators are concerned about the high prevalence of Obstructive Sleep Apnoea syndrome (OSA) in the bariatric population. Postoperatively, there is a high rate of recovery from OSA. Indeed, investigators know from previous reports that weight loss is a very effective, but time consuming, strategy for treating OSA. Patients are therefore treated with CPAP (Continuous Positive Airway Pressure) while waiting for weight loss. In a recent meta-analysis, which focused on the effect of weight loss achieved through lifestyle interventions in 618 overweight and obese patients, the apnea-hypopnea index (AHI) decreased by an amount of 16/h for an average weight loss of 14 kg (1). However, the majority of patients are not able to maintain weight loss in the long term, and weight gain is associated with recurrence/aggravation of OSAS (2). Nowadays, bariatric surgery is a common strategy to achieve sustained and significant weight loss in obese patients. Sarkhosh et al. examined the impact of bariatric surgery (restrictive procedures, with a mild malabsorption component, or largely malabsorptive procedures) on sleep apnoea in 13,900 patients. Depending on the procedure, improvement or resolution of OSAS was achieved in 78-90% of patients (3).

Prospective longitudinal postoperative follow-up study : inclusion of patients who had scheduled bariatric surgery, diagnosed with OSA, AHI > 15 (polysomnography), treated with self-controlled CPAP (APAP), under remote monitoring;

Baseline measures:

  1. Anthropometric characteristics: body mass index (BMI), neck circumference, waist/hip ratio, fat mass + lean mass (bioelectrical impedance measurements),
  2. APAP treatment characteristics, mean APAP pressure, 95th percentile APAP pressure, APAP adherence.

Follow-up:

  1. The 2-month follow-up: body mass index (BMI), neck circumference, waist/hip ratio, fat mass + fat-free mass (bioelectrical impedance measurements), mean APAP pressure, 95th percentile APAP pressure, APAP adherence. To assess potential regression of OSA with weight loss: home polygraphy after 4 nights off APAP (4).
  2. Six-month and 12-month follow-up: same as at 2 months. Follow-up stops in case of a polygraph showing an AHI \<10, allowing APAP treatment to be stopped.
03

Conditions studied

  • Obesity
  • Obstructive Sleep Apnea
04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Eligible patients from CHU St Pierre hospital setting

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Any informed person who is

  • eligible for bariatric surgery: with severe obesity (≥35-40) or morbid obesity (BMI≥40), with co-morbidities, who have not lost enough weight with prior lifestyle adaptations (balanced diet, physical activity) AND
  • with diagnosed obstructive sleep apnoea (OSA) (AHI > 15/hr on polysomnography) AND
  • requiring treatment with Continuous Positive Air Pressure (CPAP)

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment - language barrier
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
60 participants (estimated)
Target follow-up
12 Months
Patient registry
Yes

Interventions

  • ProcedureBariatric surgery

    Bariatric surgery includes (but is not limited to) * Gastric bypass: surgical bypass of the entire stomach, duodenum and approximately 1 m of the proximal small intestine * Sleeve: a large part of the stomach is removed laparoscopically, the open vertical edges are put back in place to leave a sleeve-like tube. Bariatric surgery is considered a treatment option * for patients with a BMI \>40 kg/m 2 , assuming the patient has previously participated successfully in a group weight management programme (weight loss \>7%) or * for patients with a BMI of 35-40 kg/m 2 when the obesity is associated with type 2 diabetes or hypertension, or OAS (with CPAP therapy) or severe musculoskeletal disease

06

What researchers measure

Primary outcomes

  1. Comparison of (1) the relationship between waist circumference changes and resolution of obstructive sleep apnea and (2) the relationship between the changes in waist circumference and BMI

    Comparison of (1) the correlation between waist circumference reduction and resolution of OAS (AHI\<10/hour on polysomnography) and (2) the correlation between waist circumference reduction and BMI reduction

    Time frame: 2 months

  2. Comparison of (1) the relationship between waist circumference changes and resolution of obstructive sleep apnea and (2) the relationship between the changes in waist circumference and BMI

    Comparison of (1) the correlation between waist circumference reduction and resolution of OAS (AHI\<10/hour on polysomnography) and (2) the correlation between waist circumference reduction and BMI reduction

    Time frame: 6 months

  3. Comparison of (1) the relationship between waist circumference changes and resolution of obstructive sleep apnea and (2) the relationship between the changes in waist circumference and BMI

    Comparison of (1) the correlation between waist circumference reduction and resolution of OAS (AHI\<10/hour on polysomnography) and (2) the correlation between waist circumference reduction and BMI reduction

    Time frame: 12 months

Secondary outcomes

  1. Comparison of (1) the correlation between neck circumference reduction and OAS resolution and (2) the correlation between neck circumference reduction and BMI reduction

    Comparison of (1) the correlation between neck circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between neck circumference reduction and BMI reduction

    Time frame: 2 months

  2. Comparison of (1) the correlation between neck circumference reduction and OAS resolution and (2) the correlation between neck circumference reduction and BMI reduction

    Comparison of (1) the correlation between neck circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between neck circumference reduction and BMI reduction

    Time frame: 6 months

  3. Comparison of (1) the correlation between neck circumference reduction and OAS resolution and (2) the correlation between neck circumference reduction and BMI reduction

    Comparison of (1) the correlation between neck circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between neck circumference reduction and BMI reduction

    Time frame: 12 months

  4. Comparison of (1) the correlation between hip circumference reduction and OAS resolution and (2) the correlation between hip circumference reduction and BMI reduction

    Comparison of (1) the correlation between hip circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between hip circumference reduction and BMI reduction

    Time frame: 2 months

  5. Comparison of (1) the correlation between hip circumference reduction and OAS resolution and (2) the correlation between hip circumference reduction and BMI reduction

    Comparison of (1) the correlation between hip circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between hip circumference reduction and BMI reduction

    Time frame: 6 months

  6. Comparison of (1) the correlation between hip circumference reduction and OAS resolution and (2) the correlation between hip circumference reduction and BMI reduction

    Comparison of (1) the correlation between hip circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between hip circumference reduction and BMI reduction

    Time frame: 12 months

  7. Comparison of (1) the correlation between lean mass reduction and OAS resolution and (2) the correlation between lean mass reduction and BMI reduction

    Comparison of (1) the correlation between lean mass reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between lean mass reduction and BMI reduction

    Time frame: 2 months

  8. Comparison of (1) the correlation between lean mass reduction and OAS resolution and (2) the correlation between lean mass reduction and BMI reduction

    Comparison of (1) the correlation between lean mass reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between lean mass reduction and BMI reduction

    Time frame: 6 months

  9. Comparison of (1) the correlation between lean mass reduction and OAS resolution and (2) the correlation between lean mass reduction and BMI reduction

    Comparison of (1) the correlation between lean mass reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between lean mass reduction and BMI reduction

    Time frame: 9 months

07

Study locations

2 of 2 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2022 (actual). Primary completion is estimated for Dec 2026, 56 months after the start.

Of 796 non-industry observational studies under Obesity, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 106. This study's planned 56 months is above that.

Counting every sponsor, half of 842 studies reached it within 39 months; a quarter within 17 and three quarters within 96.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2022
First posted
Apr 7, 2022
StartActual
Apr 22, 2022
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Feb 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05315752
Lead sponsor
Centre Hospitalier Universitaire Saint Pierre
Responsible party
Marie Bruyneel (Head of pneumology department, Centre Hospitalier Universitaire Saint Pierre) — Principal investigator
First posted
Apr 7, 2022
Start date
Apr 22, 2022
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Feb 13, 2024

Study contacts

Marie BRUYNEEL, Prof.
Contact
marie.bruyneel@stpierre-bru.be
+3225353686
Ionela BOLD, MD
Contact
ionela.bold@stpierre-bru.be
+3225353686

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion